logo

For the Inventor, By the Inventor

Gyeonggi-do, South Korea

Hyun Ju

USPTO Granted Patents = 15

 

Average Co-Inventor Count = 6.8

ph-index = 3

Forward Citations = 11(Granted Patents)


Location History:

  • Yongin-si, KR (2013)
  • Hwaseong-si, KR (2022 - 2023)
  • Gyeonggi-do, KR (2013 - 2024)

Company Filing History:

goldMedal15 out of 93 
 
Yuhan Corporation
 patents

Years Active: 2013-2025

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 12428401 - Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same (2025-09-30),
2. 12187714 - Process for preparing aminopyrimidine derivatives (2025-01-07),
3. 11981659 - Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same (2024-05-14),
4. 11708362 - Process for preparing aminopyrimidine derivatives (2023-07-25),
5. 11623925 - Processes for preparing a diaminopyrimidine derivative or acid addition salt thereof (2023-04-11),
6. 11453656 - Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same (2022-09-27),
7. 11434224 - Processes for preparing a diaminopyrimidine derivative or acid addition salt thereof (2022-09-06),
8. 11286253 - Process for preparing aminopyrimidine derivatives (2022-03-29),
9. 11198684 - Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same (2021-12-14),
10. 10889578 - Process for preparing aminopyrimidine derivatives (2021-01-12),
11. 10858353 - Intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same (2020-12-08),
12. 8633223 - Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds (2014-01-21),
13. 8487106 - Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds (2013-07-16),
14. 8476432 - Process for the preparation of HMG-COA reductase inhibitors and intermediates thereof (2013-07-02),
15. 8367704 - Process for preparation of 2-methyl-2' phenylpropionic acid derivatives and novel intermediate compounds (2013-02-05),

Title: Innovations and Contributions of Inventor Hyun Ju

Introduction

Hyun Ju is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of 15 patents. His work focuses on developing novel compounds and processes that enhance drug efficacy and stability.

Latest Patents

Hyun Ju's latest patents include a salt of an aminopyridine derivative compound and a crystalline form thereof. This invention relates to a novel mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide. The compound exhibits excellent stability, solubility, and bioavailability, making it effective both alone and in combination with other drugs. Another significant patent involves an improved process for preparing aminopyrimidine derivatives, which have selective inhibitory activity against protein kinases, particularly those associated with mutant epidermal growth factor receptors.

Career Highlights

Hyun Ju is currently employed at Yuhan Corporation, a leading pharmaceutical company in South Korea. His innovative work has positioned him as a key figure in the development of new therapeutic agents. His expertise in chemistry and pharmacology has led to advancements that benefit both the industry and patients.

Collaborations

Hyun Ju collaborates with notable colleagues, including Ja-Heouk Khoo and Woo-Seob Shin. Their combined efforts contribute to the success of their projects and the advancement of pharmaceutical research.

Conclusion

Hyun Ju's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for innovative solutions in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…